CureME - driving biomedical research into ME/CFS

CureME

Driving clinical & biomedical research for recognition, diagnosis and treatment of ME/CFS

The CureME research group is based at the London School of Hygiene & Tropical Medicine’s International Centre for Evidence in Disability.

CureME is at the forefront of participatory epidemiological, clinical and laboratory research into ME/CFS in the UK. Our research has focused on improving recognition, diagnosis and treatment of ME/CFS, leading to the opening of the UK’s first ME/CFS Biobank (UKMEB) – now open to researchers across the globe.

The UKMEB is the first ME/CFS-specific biobank in Europe, and one of the first in the world. It has collected over 30,000 aliquots of blood from patients with ME/CFS and multiple sclerosis (as well as healthy controls), using a rigorous and consistent set of scientific protocols.

CureME is committed to patient participation, and ensures that its research is always informed by and for the benefit of people with ME/CFS. We have contributed to highly significant research in immunology (including on NK and T cells and cytokine profiles), genetics, virology, clinical medicine, epidemiology and on the disabling effects of ME/CFS, and our Biobank has released samples to researchers in the UK, Europe, the Middle East and America.

The UKMEB was established by a consortium of charities and a private donor, and its continuing operation is funded through the generous support of the National Institutes of Health (USA) and the ME Association.